ASSERTIO THERAPEUTICS, INC. Other Nonoperating Income (Expense)
ASSERTIO THERAPEUTICS, INC. reported Other Nonoperating Income (Expense) of -$3.33 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2020-05-11
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2020-03-31 was -$3.33M.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2019-12-31 was $6.56M, a 2829.02% increase year-over-year.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2019-09-30 was -$764.00K, a 212.85% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2019-06-30 was -$1.24M, a 1950.75% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2019 was $3.95M, a 229.82% increase from fiscal 2018.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2018 was $1.20M, a 75.77% increase from fiscal 2017.
- ASSERTIO THERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2017 was $681.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$3.33M 10-Q · filed 2020-05-11 | $3.24M derived: sum of 2 quarters · filed 2020-05-11 | $2.47M derived: sum of 3 quarters · filed 2020-05-11 | $1.23M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $5.80M derived: sum of 2 quarters · filed 2020-03-10 | $4.56M derived: sum of 3 quarters · filed 2020-03-10 | $3.95M 10-K · filed 2020-03-10 |
| 2019-09-30 | -$764.00K 10-Q · filed 2019-11-07 | -$2.00M derived: sum of 2 quarters · filed 2019-11-07 | -$2.61M 10-Q · filed 2019-11-07 | -$2.39M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$1.24M 10-Q · filed 2019-08-09 | -$1.85M 10-Q · filed 2019-08-09 | -$1.63M derived: sum of 3 quarters · filed 2020-05-11 | -$948.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$609.00K 10-Q · filed 2020-05-11 | -$385.00K derived: sum of 2 quarters · filed 2020-05-11 | $292.00K derived: sum of 3 quarters · filed 2020-05-11 | $359.00K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $901.00K derived: sum of 2 quarters · filed 2020-03-10 | $968.00K derived: sum of 3 quarters · filed 2020-03-10 | $1.20M 10-K · filed 2020-03-10 |
| 2018-09-30 | $677.00K 10-Q · filed 2019-11-07 | $744.00K derived: sum of 2 quarters · filed 2019-11-07 | $973.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $67.00K 10-Q · filed 2019-08-09 | $296.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $229.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $681.00K 10-K · filed 2020-03-10 |